GLENVIEW CAPITAL MANAGEMENT, LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$3.96B
Signature - Title
Mark Horowitz - Co-President
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by GLENVIEW CAPITAL MANAGEMENT, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GLENVIEW CAPITAL MANAGEMENT, LLC reported 36 stock holdings with total value $3.96B as of Q4 2024. Top holdings included CVS, GPN, THC, ALIT, and TEVA.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 36 $3.96B +$586M -$980M -$394M CVS, GPN, THC, ALIT, TEVA 13F-HR 2/14/2025, 04:22 PM
Q3 2024 43 $4.74B +$770M -$1.19B -$424M CVS, THC, GPN, CI, CTVA 13F-HR 11/14/2024, 04:17 PM
Q2 2024 46 $4.72B +$916M -$1.15B -$231M THC, CVS, CI, GPN, CTVA 13F-HR 8/14/2024, 04:09 PM
Q1 2024 43 $5.13B +$998M -$786M +$213M THC, CI, CTVA, UHS, GPN 13F-HR 5/15/2024, 04:23 PM
Q4 2023 41 $4.29B +$805M -$699M +$105M CI, THC, DXC, UHS, GPN 13F-HR 2/14/2024, 04:26 PM
Q3 2023 61 $4.42B +$831M -$496M +$335M SPY, THC, CI, UHS, GPN 13F-HR 11/14/2023, 04:30 PM
Q2 2023 62 $4.44B +$524M -$1.14B -$611M CI, SPY, THC, DXC, UHS 13F-HR 8/14/2023, 05:13 PM
Q1 2023 54 $4.56B +$746M -$385M +$361M SPY, CI, THC, FI, GPN 13F-HR 5/15/2023, 04:18 PM
Q4 2022 53 $4.51B +$911M -$460M +$452M CI, THC, SPY, DXC, FI 13F-HR 2/14/2023, 03:21 PM
Q3 2022 54 $4B +$667M -$251M +$417M CI, THC, FI, DXC, GPN 13F-HR 11/14/2022, 03:12 PM
Q2 2022 55 $4B +$675M -$163M +$512M CI, THC, GPN, DXC, MCK 13F-HR 8/11/2022, 04:15 PM
Q1 2022 60 $4.94B +$1.1B -$691M +$409M THC, CI, GPN, MCK, DXC 13F-HR 5/16/2022, 04:43 PM
Q4 2021 53 $4.6B +$372M -$1.6B -$1.23B THC, MCK, BHC, GPN, CI 13F-HR 2/14/2022, 04:05 PM
Q3 2021 2 $55.1M $0 $0 QSI, EVLV New Holdings 2/18/2022, 05:16 PM
Q3 2021 60 $5.48B +$738M -$1B -$264M THC, BHC, MCK, CI, COR 13F-HR 11/15/2021, 04:38 PM
Q2 2021 65 $6.05B +$1.24B -$1.45B -$209M THC, BHC, CI, MCK, DXC Restatement 2/18/2022, 05:16 PM
Q1 2021 63 $5.9B +$1.79B -$1.02B +$771M THC, BHC, CI, MCK, DXC 13F-HR 5/17/2021, 04:06 PM
Q4 2020 56 $4.36B +$715M -$476M +$238M THC, BHC, TAK, DXC, CI 13F-HR 2/16/2021, 03:16 PM
Q3 2020 45 $3.19B +$122M -$777M -$655M THC, TAK, BHC, CI, HCA 13F-HR 11/16/2020, 03:09 PM
Q2 2020 44 $3.63B +$520M -$1.09B -$570M THC, TAK, BHC, CI, HCA 13F-HR 8/14/2020, 04:06 PM
Q1 2020 44 $3.68B +$239M -$3.17B -$2.93B TAK, THC, CI, BHC, HCA 13F-HR 5/15/2020, 04:07 PM
Q4 2019 50 $11.4B +$2.01B -$1.37B +$640M HCA, CI, THC, PARA, TAK 13F-HR 2/14/2020, 03:18 PM
Q3 2019 49 $9.51B +$1.05B -$1.38B -$337M CI, HCA, MCK, IQV, TAK 13F-HR 11/14/2019, 03:07 PM
Q2 2019 46 $11B +$1.08B -$1.12B -$32.6M CI, HCA, IQV, FMC, MCK 13F-HR 8/14/2019, 04:07 PM
Q1 2019 45 $11.2B +$2.93B -$838M +$2.09B DXC, FMC, CI, MCK, IQV 13F-HR 5/15/2019, 04:06 PM
Q4 2018 50 $10.3B +$1.88B -$1.81B +$67.5M SHPG, FMC, IQV, HCA, CVS 13F-HR 2/14/2019, 03:12 PM
Q3 2018 58 $15.7B +$1.99B -$1.99B -$4.58M ESRX, FMC, AET, IQV, MCK 13F-HR 11/14/2018, 03:09 PM
Q2 2018 50 $14.7B +$936M -$3.07B -$2.13B SHPG, DWDP, FMC, MCK, THC 13F-HR 8/14/2018, 04:08 PM
Q1 2018 53 $17.1B +$1.99B -$1.77B +$222M HCA, SHPG, DWDP, FMC, IQV 13F-HR 5/15/2018, 04:07 PM
Q4 2017 58 $18.5B +$4.5B -$2.32B +$2.17B HCA, DWDP, FMC, SHPG, IQV 13F-HR 2/14/2018, 03:26 PM
Q3 2017 56 $17.2B +$3.5B -$940M +$2.56B HCA, DWDP, FMC, SHPG, Q 13F-HR 11/14/2017, 03:18 PM
Q2 2017 52 $15.4B +$2.67B -$2.08B +$588M HCA, FMC, DOW, Q, ELV 13F-HR 8/14/2017, 04:26 PM
Q1 2017 52 $15.1B +$1.36B -$1.9B -$536M HCA, HUM, ELV, DOW, FMC 13F-HR 5/15/2017, 04:23 PM
Q4 2016 49 $14.8B +$2.8B -$1.58B +$1.22B HCA, HUM, ELV, CIXXXX, AET 13F-HR 2/14/2017, 03:25 PM
Q3 2016 50 $14B +$2.14B -$960M +$1.18B HUM, HCA, CIXXXX, CBS, ELV 13F-HR 11/14/2016, 03:20 PM
Q2 2016 47 $14.1B +$1.7B -$759M +$942M HUM, HCA, MON, CIXXXX, ABBV 13F-HR 8/15/2016, 04:10 PM
Q1 2016 45 $13.7B +$478M -$2.51B -$2.04B HUM, HCA, MON, CIXXXX, ABBV 13F-HR 5/16/2016, 04:11 PM
Q4 2015 54 $17.8B +$2.84B -$2.42B +$417M HUM, MON, CIXXXX, HCA, TMO 13F-HR 2/16/2016, 03:52 PM
Q3 2015 78 $20.2B +$2.25B -$2.34B -$81.7M HUM, MON, TMO, ABBV, FLEX 13F-HR 11/16/2015, 03:11 PM
Q2 2015 81 $25.3B +$6.56B -$1.99B +$4.57B HUM, TMO, ABBV, MON, THC 13F-HR 8/14/2015, 04:11 PM
Q1 2015 80 $21.9B +$4.2B -$2.14B +$2.06B MON, FLEX, TMO, HUM, ELV 13F-HR 5/15/2015, 04:18 PM
Q4 2014 74 $20B +$3.14B -$1.5B +$1.64B TMO, MON, FLEX, THC, CYH 13F-HR 2/17/2015, 03:13 PM
Q3 2014 74 $19.1B +$4.14B -$1.47B +$2.67B TMO, MON, THC, FLEX, HCA 13F-HR 11/14/2014, 03:09 PM
Q2 2014 69 $17.3B +$3.81B -$1.24B +$2.57B TMO, MON, FLEX, HCA, THC 13F-HR 8/14/2014, 04:14 PM
Q1 2014 67 $15.3B +$4.31B -$1.34B +$2.96B TMO, MON, HCA, CCIXXXX, THC 13F-HR 5/15/2014, 04:10 PM
Q4 2013 66 $14B TMO, HCA, THC, MON, CCIXXXX 13F-HR 2/14/2014, 03:20 PM